Principia Wealth Advisory’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Principia Wealth Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.9K	Buy	115 +19	+20%	+$633	﹤0.01%	419
2026 Q1	$2.89K	Buy	96 +17	+22%	+$547	﹤0.01%	423
2025 Q4	$2.47K	Sell	79 -1	-1%	-$25	﹤0.01%	402
2025 Q3	$1.62K	Buy	80 +58	+264%	+$1.02K	﹤0.01%	485
2025 Q2	$369	Buy	+22	New	+$355	﹤0.01%	802

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Principia Wealth Advisory's TEVA Position: Q2 2026 in Review

Principia Wealth Advisory increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 20% in Q2 2026, buying an estimated $633 and bringing the position to 115 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #419.

Principia Wealth Advisory first reported a position in TEVA in Q2 2025 and has held it in 5 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Principia Wealth Advisory held 115 shares of Teva Pharmaceutical Industries Limited worth $3.9K as of Q2 2026.
Principia Wealth Advisory bought 19 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $633.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #419 holding.
Principia Wealth Advisory first reported a position in Teva Pharmaceutical Industries Limited in Q2 2025 and has held it in 5 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.